Be Prepared for the US 2018 Deadline

Do you know the requirements that must be met by January 1, 2018 for USP <232> and USP <233> in the United States? Our experts developed this white paper to help manufacturers demonstrate compliance with these standards. This paper will:

  • Serve as a guide to the proper risk assessment and testing of drug products in order to demonstrate compliance with USP <232> and USP <233> requirements.
  • Provide steps needed for elemental impurities risk assessment and testing to help ensure a fast and efficient path to market for your products. 

Complete the form below to download the complimentary white paper: Elemental Impurities: A Guide to Risk Assessment and Testing.